Boston Pharmaceuticals Receives $600,000,000 New Round

  • Feed Type
  • Date
    11/20/2015
  • Company Name
    Boston Pharmaceuticals
  • Mailing Address
    Undisclosed Cambridge, MA 02138 USA
  • Company Description
    This is a new way to develop and to bring to market innovative medicines. We believe that the combination of our dedicated capital pool and extensive industry expertise will give Boston Pharmaceuticals a significant competitive advantage in this space.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $600,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Boston Pharmaceuticals is a fully-integrated drug development company that will offer an innovative alternative model for drug development and commercialization.
  • M&A Terms
  • Venture Investor
    Gurnet Point Capital
  • Venture Investor
    Investor

Trending on Xconomy